Related Experiment Video
Updated: Aug 2, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Interpreting posterior relative risk estimates in disease-mapping studies
Sylvia Richardson1, Andrew Thomson, Nicky Best
1Department of Epidemiology and Public Health, Imperial College Faculty of Medicine, Imperial College London, Norfolk Place, London, United Kingdom. sylvia.richardson@imperial.ac.uk
Bayesian disease-mapping models show high specificity but low sensitivity for moderate excess risks in sparse health data. A probability cutoff rule improves detection of true raised-risk areas.
Area of Science:
- Spatial epidemiology
- Biostatistics
- Geographic Information Systems (GIS) in health
Background:
- Small-area health outcome analysis requires sophisticated Bayesian models to smooth sparse data.
- Concerns exist regarding model performance, prior influence, and smoothing levels in risk estimation.
Purpose of the Study:
- To evaluate the performance of Bayesian disease-mapping models in recovering true health risk surfaces.
- To assess the impact of prior structures and smoothing on risk estimates.
- To compare different Bayesian models and propose improved detection methods.
Main Methods:
- Comprehensive simulation study of Bayesian disease-mapping models.
- Comparison of conditional autoregressive (CAR) and semiparametric spatial mixture models.
- Evaluation of model specificity and sensitivity with varying data sparsity and risk levels.
- Development and testing of a decision rule based on posterior probability of relative risk.
Main Results:
- Bayesian models are conservative with high specificity but low sensitivity for moderate excess risks (<2-fold) or low expected counts (<50).
- Semiparametric models smooth less than CAR models when data provide sufficient information (moderate counts or high risk).
- A decision rule using posterior probability (70-80% cutoff) offers reasonable sensitivity for moderate excess risks (1.5-2 fold) and moderate counts (~20).
Conclusions:
- Bayesian disease-mapping models require careful consideration of prior structure and smoothing.
- Exploiting the full posterior distribution enhances sensitivity for detecting true raised-risk areas.
- The proposed probability-based decision rule improves the detection of moderate excess risks in spatial health analyses.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk
Odds Ratio
Comparing the Survival Analysis of Two or More Groups
Hazard Ratio
For example, in a clinical trial evaluating a...

